Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

-Trinity Biotech projects it reached Adjusted EBITDA¹ -positive operations during Q2 2025 and expects to be Adjusted EBITDA¹ positive going forward, reflecting continued strong execution on its comprehensive transformation plan.-